Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

A good couple of months

Generation Development Group
3:27pm
March 18, 2025
GDG has released its 1H25 result and also announced the acquisition of Evidentia. Overall, we saw the 1H25 result as strong across the board, whilst the Evidentia acquisition solidifies GDG’s leading position in the attractive Managed Account space. We increase our GDG FY25F/FY26F EPS by 3%-7% on incorporation of the Evidentia acquisition into our forecasts, and also earnings changes from the 1H25 result. We lift our GDG target price to A$5.59 (previously A$4.75). GDG has a strong structural growth story, and management continue to execute well. With >10% upside to our target price, we maintain our ADD recommendation.

El Golden Chile

Tesoro Gold
3:27pm
March 17, 2025
Coverage of TSO initiated with a SPECULATIVE BUY rating, target price A$0.11ps. TSO’s 1.5Moz Ternera deposit exhibits strong fundamentals, indicative of producing +90kozpa at an AISC of US$1,068/oz whilst generating +A$130m EBITDA per annum. Ternera is free of fatal flaws with plenty of catalysts (drill results, MRE update and PFS) whilst backed by gold mining major Goldfields (17.5%). Chile is a reputable mining jurisdiction with an established mining code, skilled workforce and royalty free gold production.

The final piece of Queensland’s energy puzzle?

Omega Oil & Gas
3:27pm
March 17, 2025
We initiate research coverage on Omega Oil & Gas (OMA) with a Speculative Buy rating and A$0.64 target price. OMA’s flagship Canyon Gas Project has a ~1.7 TCFe resource located strategically close to the east coast gas market. Early frac results from Canyon-1H are encouraging, with flowback now underway. OMA is trading at a discounted A$0.07/GJe (vs undeveloped peers at A$0.21/GJe). Gas producers trade on A$0.77/GJe showing the ultimate ‘size of the prize’.

Getting on with it

Neurizon Therapeutics
3:27pm
March 17, 2025
NUZ is planning to commence two animal studies in the coming weeks which are expected to take four months from start to finish. The studies aim to address the questions FDA placed on NUZ-001 around systemic exposure. Positive data here is required to remove the roadblock currently in the way on its entry into the HEALEY ALS Platform trial. The delays push timelines to trial commencement by ~6 months, and to the end of the 12-month buffer we originally placed on the program for unforeseen delays. Key here will be positive feedback from the FDA which aligns with the studies NUZ will have already commenced. No changes to forecasts although note the additional timelines to trial commencement due to the additional studies sit at the limit of our model assumptions.

Cessation of coverage

Arcadium Lithium
3:27pm
March 16, 2025
We discontinue coverage of Arcadium Lithium (LTM) following the company being acquired by Rio Tinto Limited (RIO). Our forecasts, target price and recommendation should no longer be relied upon for investment decisions.

1H’FY25 result: focused on ramp-up and improving recoveries

Liontown Resources
3:27pm
March 14, 2025
LTR reported an in-line result with key cash flow items largely pre-reported. Underlying EBITDA of A$66m was ahead of expectations as LTR capitalised all costs related to LTR ramp-up as LTR declared commercial production post 1H’FY25. Net debt is A$651m which is in-line with expectations. We maintain our Hold rating with a A$0.66ps Target Price (previously A$0.68ps).

International Spotlight

Constellation Software
3:27pm
March 14, 2025
Constellation Software (CSU) acquires, manages and builds industry specific software businesses aka Vertical Market Software (VMS) companies. Uniquely they are perpetual owners of all their businesses. CSU has six operating groups: Volaris, Harris, Jonas, Vela Software, Perseus Group and Topicus, which service customers in over 100 markets worldwide. Each operating group serves as a holding company for dozens of underlying software companies. The company is headquartered in Toronto, Canada, and has offices in North America, Europe, Australia, South America and Africa.

Fundamentals look the best in years

Orica
3:27pm
March 12, 2025
ORI’s trading update was stronger than expected and has resulted in both us and consensus upgrading 1H25 and FY25 forecasts. Pleasingly, given its strong balance sheet, ORI has announced up to A$400m on-market share buyback. With a leverage to attractive industry fundamentals, market leading positions, strong earnings growth, proven management team and strong balance sheet, we think ORI’s trading multiples are undemanding and reiterate our Add rating.

A mixed 1H25 result

COG Financial Services
3:27pm
March 11, 2025
COG’s 1H25 NPATA attributable to shareholders (A$11.8m) came in slightly ahead of unaudited guidance given on 29 January (A$11.6m). We saw the 1H25 result as a mixed outcome overall. The Novated Leasing business continues to deliver strong results, but that was offset by tougher conditions in COG’s other divisions. We lower our COG FY25F/FY26F EPS by ~1%-4% mainly on lower top-line growth assumptions across COG’s various businesses. Our target price is set at A$1.09 (previously $1.16). We maintain our Speculative Buy call.

Trading update confirms materials slowdown

Brickworks
3:27pm
March 11, 2025
BKW has issued a 1H25 trading update, flagging particular weakness across its North American building materials business, with Australian building materials flat (vs pcp). Whilst largely expected, the share price move has notionally written off the majority of value ascribed by the market to the building materials division. As we look forward we struggle to see catalysts for BKW, with investment market uncertainty to likely outweigh any potential tailwinds from rental income growth across the industrial property portfolio. We retain our Hold rating, with a $25.00/sh price target.

News & Insights

The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more
Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more